Inhibition of cytokine-induced MHC class II but not class I molecule expression on mouse islet cells by niacinamide and 3-aminobenzamide
- PMID: 2143488
- DOI: 10.2337/diab.39.9.1125
Inhibition of cytokine-induced MHC class II but not class I molecule expression on mouse islet cells by niacinamide and 3-aminobenzamide
Abstract
Normal mouse islet cells express low levels of MHC class I molecules and undetectable or extremely low levels of MHC class II molecules. Class I expression was dose-dependently augmented by incubation with interferon-gamma (IFN-gamma) or tumor necrosis factor (TNF). Although neither IFN-gamma nor TNF alone induce class II molecules on islet cells, synergistic interaction of IFN-gamma (200 U/ml) and TNF (200 U/ml) may induce class II expression on approximately 50% of islet cells. Niacinamide and 3-aminobenzamide, both inhibitors of ADP ribosylation and scavengers of free radicals, attenuated the class II expression induced by IFN-gamma and TNF. Twenty millimolar niacinamide and 10 mM 3-aminobenzamide reduced the rates of class II antigen-positive cells to mean +/- SD 3.6 +/- 0.3 and 6.1 +/- 1.9%, respectively. The agents did not affect the cytokine-induced augmentation of class I antigens. The inhibition of class II molecule expression may at least partly account for the preventive effect of niacinamide on autoimmune-associated beta-cell damage in NOD mice.
Similar articles
-
Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.Immunopharmacol Immunotoxicol. 1991;13(3):263-80. doi: 10.3109/08923979109019705. Immunopharmacol Immunotoxicol. 1991. PMID: 1834724
-
IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.Diabetologia. 2002 Mar;45(3):385-93. doi: 10.1007/s00125-001-0755-8. Diabetologia. 2002. PMID: 11914744
-
MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.J Exp Med. 1989 Oct 1;170(4):1243-62. doi: 10.1084/jem.170.4.1243. J Exp Med. 1989. PMID: 2507727 Free PMC article.
-
MHC molecules and beta-cell destruction. Immune and nonimmune mechanisms.Diabetes. 1989 Jul;38(7):815-8. doi: 10.2337/diab.38.7.815. Diabetes. 1989. PMID: 2661283 Review.
-
Major histocompatibility complex molecules and the beta cell: inferences from transgenic models.Curr Top Microbiol Immunol. 1990;156:121-35. doi: 10.1007/978-3-642-75239-1_9. Curr Top Microbiol Immunol. 1990. PMID: 2199163 Review. No abstract available.
Cited by
-
Endogenous metabolism in endothelial and immune cells generates most of the tissue vitamin B3 (nicotinamide).iScience. 2022 Oct 23;25(11):105431. doi: 10.1016/j.isci.2022.105431. eCollection 2022 Nov 18. iScience. 2022. PMID: 36388973 Free PMC article.
-
Composition of human islet cell preparations for transplantation.Acta Diabetol. 1992;28(3-4):233-8. doi: 10.1007/BF00779005. Acta Diabetol. 1992. PMID: 1576361 Free PMC article.
-
Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.Diabetologia. 2003 Aug;46(8):1106-14. doi: 10.1007/s00125-003-1164-y. Epub 2003 Jul 10. Diabetologia. 2003. PMID: 12856083
-
Effect of nicotinamide on early graft failure following intraportal islet transplantation.Exp Mol Med. 2009 Nov 30;41(11):782-92. doi: 10.3858/emm.2009.41.11.084. Exp Mol Med. 2009. PMID: 19641379 Free PMC article.
-
Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide.Diabetologia. 1991 May;34(5):362-5. doi: 10.1007/BF00405010. Diabetologia. 1991. PMID: 1830860 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials